Indoco Remedies’ Warren Remedies commences commercial production in Aurangabad

TAGS

Warren Remedies Private Limited, a wholly-owned subsidiary of Indoco Remedies Limited, has officially started its commercial operations on March 1, 2024. The new Greenfield manufacturing facility, located in Aurangabad, Maharashtra, is set to produce a range of oral care products. This strategic move aims to bolster the company’s manufacturing capabilities and meet the growing demand for oral care products in the market.

Aditi Panandikar, the Managing Director of Indoco Remedies Ltd, expressed her enthusiasm regarding the launch. “It gives us immense pleasure to announce that Warren Remedies Private Limited, Wholly Owned Subsidiary of Indoco Remedies has commenced its commercial production of Oral Care Products to cater to the needs of its customers. The said manufacturing facility will provide us requisite capabilities and edge in meeting demand of Oral Care Products,” she stated. This development is a significant step for Indoco Remedies as it seeks to expand its footprint in the oral care segment.

See also  AstraZeneca Pharma India, Mankind Pharma announce distribution partnership for asthma medication Symbicort

Indoco Remedies Limited is a renowned name in the pharmaceutical industry, known for its research-oriented approach and global presence in 55 countries. The company boasts a turnover of US$ 200 million and employs a dedicated workforce of 6000, including over 300 skilled scientists and field staff. Indoco operates nine manufacturing facilities—six for Finished Dosage Forms (FDFs) and three for Active Pharmaceutical Ingredients (APIs)—backed by a state-of-the-art R&D Centre and a Clinical Research Organization (CRO) facility. These facilities have earned accolades and approvals from major regulatory authorities worldwide, including the USFDA and UK-MHRA.

See also  AstraZeneca Pharma India, Mankind Pharma announce distribution partnership for asthma medication Symbicort

Indoco’s diverse portfolio caters to a variety of therapeutic segments, including gastro-intestinal, respiratory, anti-infective, and more, generating over 109 million prescriptions annually. The company’s strong domestic and international presence is further enhanced by strategic partnerships with leading generic companies globally.

The inauguration of Warren Remedies Private Limited’s manufacturing unit marks a significant milestone for Indoco Remedies Limited, showcasing its commitment to innovation and customer satisfaction in the oral care market. This expansion not only strengthens Indoco’s manufacturing capabilities but also positions the company for further growth and competitiveness in both domestic and international markets.

CATEGORIES
TAGS
Share This